NKGen Biotech Corp (NKGN) - Year-over-year net earnings per share growth for the last 12 months

Graphic logo of NKGen Biotech (NKGN)

NKGen Biotech, Inc. (NKGN) is developing cell therapy to combat neurodegeneration, where manual cultivation limits pipeline production. Changes in quarterly EPS dynamics illustrate the current revenue drawdown, while 0.00 reflects the metric's baseline. High profitability is driven by the global scaling of proprietary methods. Operational resilience is maintained by delegating clinical trials to a network of external research laboratories.

nkgenbiotech.com (NKGN) - Year-over-year earnings per share growth for the last twelve months from 02/21/2024 to 03/15/2025

Analytical breakdowns for NKGen Biotech, Inc.

- market value and analyst target forecast:
Fundamental company valuation:nkgenbiotech.com - NKGN
Manufactured product of nkgenbiotech.com

Developing cell therapies to combat Alzheimer's and Parkinson's diseases requires colossal expenditures, which directly impacts the net income of NKGen Biotech, Inc. (NKGN). This trend captures the percentage change in earnings per share per quarter, allowing for the exclusion of one-time anomalies and an assessment of the impact of operating expenses on margins through the relative growth of quarterly EPS.

Analysis of competing companies

BIIB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Bioscience Ltd) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Therapeutics, Inc. AXSM|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals Inc.)|XENE: Year-over-year net earnings per share trend for the last twelve months|Viking Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Supernus Pharmaceuticals (SUPN)|CPRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months DNLI (Denali Therapeutics)|HRMY: Quarterly EPS earnings growth|BHVN (Biohaven Pharmaceutical) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amylyx|Quarterly EPS earnings growth Trevi Corp|Quarterly EPS earnings growth PRAX|AVXL (anavex.com) - Year-over-year earnings per one share growth for the last 12 months|CeriBell Inc - Year-over-year net earnings per share growth for the last 12 months|PRTA (Prothena Corporation plc) - Year-over-year net earnings per share trend for the last twelve months|ALEC - Year-over-year earnings per share growth for the last twelve months|ANNX (Annexon Biosciences Inc.) - Year-over-year earnings per share growth for the last 12 months|OMER (omeros.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months NGNE|Year-over-year net earnings per share growth for the last 12 months ACIU|Quarterly EPS earnings growth Voyager Pharma|Year-over-year net earnings per share growth for the last 12 months NMRA (Neumora Therapeutics, Inc.)|SCLX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tevogen Bio TVGN|Alpha Cognition Corp (ACOG) - Earnings per share growth in annualized terms for the last twelve months|CGTX: Year-over-year net earnings per share growth for the last 12 months|Inhibikase Therapeutics, Inc. - Year-over-year earnings per share growth rate for the last twelve months|SAVA: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ASRT|COYA (coyatherapeutics.com) - Quarterly EPS earnings growth|Vistagen (VTGN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OVID (Ovid Rx)|Year-over-year net earnings per share change for the last twelve months Acumen Pharmaceuticals, Inc.|Quarterly EPS earnings growth CRVO (CervoMed Corporation)|Year-over-year earnings per share growth rate for the last twelve months ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year pepgen.com (PEPG)|JUNS: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RLMD|ANVS (Annovis Bio Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Grace Therapeutics, Inc. (GRCE)|Quarterly EPS earnings growth AIFF|Year-over-year earnings per share growth rate for the last twelve months KLTO|Year-over-year earnings per share growth for the last twelve months neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth in annualized terms for the last twelve months|MetaVia Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Year-over-year net earnings per share growth for the last 12 months|Passage Bio Inc. (PASG) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Neuphoria|Year-over-year net earnings per share growth for the last 12 months Minerva Neurosciences, Inc. (NERV)|Year-over-year earnings per share growth for the last twelve months Athira (ATHA)|Addex Therapeutics - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth in annualized terms for the last twelve months|PTIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Year-over-year earnings per share growth for the last twelve months|Avenue Therapeutics - Year-over-year earnings per one share growth for the last 12 months|BCLI (brainstorm-cell.com) - Quarterly EPS earnings growth|CARA: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share growth for the trailing year Longboard Pharma|MRNS - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Year-over-year earnings per share growth for the last twelve months|SNPX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Trevena, Inc|Vigil Neuroscience (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Quarterly EPS earnings growth cerevel.com (CERE)